After 20 years of waiting, there’s a new drug to treat Alzheimer’s. For some patients, it’s a glimmer of hope. For some scientists, it’s one of the FDA’s worst drug approval decisions ever.

Transcript at vox.com/todayexplained.

Support Today, Explained by making a financial contribution to Vox! bit.ly/givepodcasts.

Learn more about your ad choices. Visit podcastchoices.com/adchoices